These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36318340)

  • 21. Dental pathologies in tumor patients with bone metastases or multiple myeloma scheduled for antiresorptive therapy.
    Laimer J; Hechenberger M; Müller D; Walch B; Kolk A; Schnabl D; Schomaker M; Bruckmoser E
    Future Oncol; 2021 Jul; 17(21):2705-2711. PubMed ID: 33880956
    [No Abstract]   [Full Text] [Related]  

  • 22. [Osteonecrosis of the jaw].
    Drozdzowska B
    Endokrynol Pol; 2011; 62 Suppl 3():4-9. PubMed ID: 22161980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Where are we going with bisphosphonates?].
    Ben Slama L
    Rev Stomatol Chir Maxillofac; 2006 Dec; 107(6):413-4. PubMed ID: 17194989
    [No Abstract]   [Full Text] [Related]  

  • 24. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?
    Somay E
    Osteoporos Int; 2023 Oct; 34(10):1811-1812. PubMed ID: 37418153
    [No Abstract]   [Full Text] [Related]  

  • 26. Bisphosphonates--role in cancer therapies.
    Mehrotra B
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):19-26. PubMed ID: 19371811
    [No Abstract]   [Full Text] [Related]  

  • 27. [Bisphosphonates-induced osteonecrosis of the jaw: CT-findings].
    Maksimovic O; Denecke B; Pintoffl JP; Horger M
    Rofo; 2008 Apr; 180(4):277-9. PubMed ID: 18432565
    [No Abstract]   [Full Text] [Related]  

  • 28. Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS.
    Anastasilakis AD; Pepe J; Napoli N; Palermo A; Magopoulos C; Khan AA; Zillikens MC; Body JJ
    J Clin Endocrinol Metab; 2022 Apr; 107(5):1441-1460. PubMed ID: 34922381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thirteen cases of jaw osteonecrosis in patients on bisphosphonate therapy.
    Vieillard MH; Maes JM; Penel G; Facon T; Magro L; Bonneterre J; Cortet B
    Joint Bone Spine; 2008 Jan; 75(1):34-40. PubMed ID: 17981488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bisphosphonate therapy for skeletal malignancies and metastases: impact on jaw bones and prosthodontic concerns.
    Tripathi A; Pandey S; Singh SV; Kumar Sharma N; Singh R
    J Prosthodont; 2011 Oct; 20(7):601-3. PubMed ID: 21883630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bisphosphonate-associated osteonecrosis of the jaws in lung cancer patients].
    Neves I; Morais A; Magalhães A
    Rev Port Pneumol; 2013; 19(5):228-32. PubMed ID: 23830508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multicenter observational study on Medication-Related Osteonecrosis of the Jaw (MRONJ) in advanced cancer and myeloma patients of a cancer network in North-Western Italy.
    Fusco V; Cabras M; Erovigni F; Dell'Acqua A; Arduino PG; Pentenero M; Appendino P; Basano L; Ferrera FD; Fasciolo A; Caka M; Migliario M
    Med Oral Patol Oral Cir Bucal; 2021 Jul; 26(4):e466-e473. PubMed ID: 33340073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Spontaneous" medication-related osteonecrosis of the jaw; two case reports and a systematic review.
    Khominsky A; Lim M
    Aust Dent J; 2018 Dec; 63(4):441-454. PubMed ID: 30144095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment.
    Migliorati CA; Siegel MA; Elting LS
    Lancet Oncol; 2006 Jun; 7(6):508-14. PubMed ID: 16750501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.
    Ruggiero SL; Dodson TB; Assael LA; Landesberg R; Marx RE; Mehrotra B;
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):2-12. PubMed ID: 19371809
    [No Abstract]   [Full Text] [Related]  

  • 36. A time for perspective on bisphosphonates.
    Assael LA
    J Oral Maxillofac Surg; 2006 Jun; 64(6):877-9. PubMed ID: 16713799
    [No Abstract]   [Full Text] [Related]  

  • 37. Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma.
    Diego R; D'Orto O; Pagani D; Agazzi A; Marzano U; Derada Troletti G; Fontanella W; Pignataro L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e1-5. PubMed ID: 17197204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteonecrosis of the Jaw.
    Hamdy RC
    J Clin Densitom; 2017; 20(1):1-2. PubMed ID: 28259260
    [No Abstract]   [Full Text] [Related]  

  • 39. Bisphosphonate osteonecrosis of the jaws in cancer patients.
    Kyrgidis A; Andreadis C
    Breast; 2009 Oct; 18(5):335. PubMed ID: 19783147
    [No Abstract]   [Full Text] [Related]  

  • 40. Osteonecrosis of the jaw induced by bisphosphonates therapy in bone metastases patient: Case report and literature review.
    Hao L; Tian Z; Li S; Yan K; Xue Y
    Oral Oncol; 2022 May; 128():105852. PubMed ID: 35439709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.